Drug:
Reaction: RASH
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26555373 |
US |
79 | 2 |
Diarrhoea, Rash, |
||||
LENALIDOMIDE, ACYCLOVIR, ATENOLOL, LOSARTAN, |
||||
| 2 | 26555382 |
46 | ||
Rash, |
||||
BIMEKIZUMAB, IXEKIZUMAB, |
||||
| 3 | 26555445 |
AR |
67 | 1 |
Urticaria, Pruritus, Rash, Acne pustular, Dry skin, Epistaxis, Skin fissures, Miliaria, Perioral dermatitis, Sensitive skin, Skin burning sensation, Erythema, Lip dry, Skin disorder, Off label use, |
||||
PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, |
||||
| 4 | 26555471 |
GB |
1 | 2 |
Rash, |
||||
| 5 | 26555474 |
US |
1 | |
Rash, |
||||
SODIUM ZIRCONIUM CYCLOSILICATE, |
||||
| 6 | 26555609 |
GB |
61 | 1 |
Rash, |
||||
RAMIPRIL, INDAPAMIDE, |
||||
| 7 | 26555648 |
CA |
86 | 2 |
Blood creatinine increased, Pruritus, Rash, |
||||
PANTOPRAZOLE, APIXABAN, BISOPROLOL FUMARATE, CALCIUM CARBONATE, ANTACID, CANDESARTAN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ERGOCALCIFEROL, POLYETHYLENE GLYCOL, LEVOTHYROXINE SODIUM, |
||||
| 8 | 26555787 |
AU |
29 | |
Colitis ulcerative, Hidradenitis, Rosacea, Drug specific antibody present, Rash, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, VEDOLIZUMAB, |
||||
| 9 | 26555794 |
US |
2 | |
Rash, Discomfort, |
||||
APREMILAST, |
||||
| 10 | 26555810 |
EU |
45 | |
Rash, Hypothyroidism, |
||||
ATEZOLIZUMAB, CISPLATIN, ETOPOSIDE, |
||||
| 11 | 26555837 |
US |
43 | 2 |
Rash, Injection site rash, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 12 | 26556045 |
US |
64 | 2 |
Full blood count decreased, Pyrexia, Rash, |
||||
LENALIDOMIDE, |
||||
| 13 | 26556074 |
AR |
66 | 2 |
Anal incontinence, Rectal haemorrhage, Hepatitis, Skin burning sensation, Swollen tongue, Mouth swelling, Eating disorder, Pain, Rash, Pruritus, Exfoliative rash, Decreased immune responsiveness, Colostomy bag user, Acne pustular, Ill-defined disorder, Rash macular, Erythema, Blister, Malaise, Discomfort, Skin haemorrhage, Dysarthria, Drug ineffective, Dry skin, Off label use, Drug hypersensitivity, Flatulence, Blood test abnormal, Magnetic resonance imaging abnormal, Therapy interrupted, Musculoskeletal pain, |
||||
PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, |
||||
| 14 | 26556134 |
US |
17 | 2 |
Somnolence, Off label use, Rash, Muscle spasms, Off label use, Seizure, |
||||
STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, STIRIPENTOL, CLOBAZAM, CLOBAZAM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ERGOCALCIFEROL, ERGOCALCIFEROL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MELATONIN, MELATONIN, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, |
||||
| 15 | 26556141 |
US |
57 | |
Feeling hot, Rash, Burning sensation, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 16 | 26556167 |
BR |
31 | 2 |
Rash, |
||||
CARMUSTINE, |
||||
| 17 | 26556216 |
US |
||
Rash, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 18 | 26556318 |
US |
||
Rash, |
||||
VELPATASVIR AND SOFOSBUVIR, |
||||
| 19 | 26556430 |
US |
68 | 1 |
Myelosuppression, Rash, |
||||
POMALIDOMIDE, |
||||
| 20 | 26556451 |
US |
38 | |
Rash, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 21 | 26556453 |
US |
||
Rash, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 22 | 26556461 |
EU |
1 | 2 |
Jaundice, Muscle tightness, Metabolic disorder, Sleep disorder, Vaccination site induration, Dermatitis atopic, Infection, Upper respiratory tract infection, Vaccination site oedema, Mucous stools, Feeding disorder, Faeces discoloured, Crying, Urticaria, Abdominal pain, Oral candidiasis, Vaccination site erythema, Diarrhoea, Decreased appetite, Irritability, Weight gain poor, Altered state of consciousness, Diarrhoea haemorrhagic, Immune system disorder, Syncope, Poor feeding infant, Abdominal pain upper, Lethargy, Seizure, Dermatitis allergic, Nasopharyngitis, Somnolence, Erythema, Rash, Vaccination site pain, Nervousness, Vomiting, |
||||
| 23 | 26556587 |
|||
Rash, |
||||
BIMEKIZUMAB, ACYCLOVIR, BIOTIN, CYANOCOBALAMIN, ETANERCEPT, ESCITALOPRAM OXALATE, ESCITALOPRAM, FOLIC ACID, LORAZEPAM, METHOTREXATE SODIUM, VARENICLINE TARTRATE, ASCORBIC ACID, |
||||
| 24 | 26556594 |
US |
57 | |
Rash, Off label use, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 25 | 26556790 |
US |
71 | 1 |
Immunosuppression, Cataract, Cellulitis, Fluid retention, Peripheral swelling, Dyspepsia, Hypoaesthesia, Paraesthesia, Myalgia, Irritability, Product dose omission issue, Muscle spasms, Fatigue, Vision blurred, Rash pruritic, Diarrhoea, Rash, |
||||
IXAZOMIB, IXAZOMIB, IXAZOMIB, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DENOSUMAB, |
||||
| 26 | 26556948 |
US |
29 | 2 |
Rash, Skin lesion, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 27 | 26556951 |
US |
44 | 2 |
Pruritus, Rash, |
||||
DUPILUMAB, |
||||
| 28 | 26556952 |
US |
58 | 2 |
Rash, |
||||
DUPILUMAB, |
||||
| 29 | 26557012 |
GB |
1 | |
Rash, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 30 | 26557013 |
GB |
78 | 2 |
Rash, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, AMLODIPINE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, MIRTAZAPINE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SENNOSIDES, SENNA LEAF, SENNA, |
||||
| 31 | 26557041 |
GB |
1 | |
Rash, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, LACOSAMIDE, |
||||
| 32 | 26557046 |
GB |
37 | |
Rash, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 33 | 26557133 |
JP |
6 | 2 |
Hyperglycaemia, Rash, Liver disorder, |
||||
FULVESTRANT, FULVESTRANT, CAPIVASERTIB, |
||||
| 34 | 26557139 |
AR |
65 | 2 |
Metastases to liver, Post procedural complication, Colon operation, Nasal discomfort, Feeling cold, Muscle spasms, Blister, Diarrhoea, Nausea, Dry skin, Nail disorder, Feeling hot, Pruritus, Gastrointestinal disorder, Vision blurred, Sneezing, Onychomadesis, Skin haemorrhage, Rhinitis, Skin laceration, Sensory loss, Retching, Limb injury, Impaired healing, Temperature intolerance, Loss of personal independence in daily activities, Pain in extremity, Nasal dryness, Cough, Epistaxis, Skin fissures, Rash, Localised infection, Acne, Erythema, Drug ineffective, Muscle spasms, |
||||
PANITUMUMAB, OXALIPLATIN, OXALIPLATIN, |
||||
| 35 | 26557295 |
CN |
62 | 2 |
Urticaria, Pruritus, Rash, |
||||
FRUQUINTINIB, |
||||
| 36 | 26557344 |
US |
1 | |
Rash, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 37 | 26557391 |
US |
59 | 2 |
Adjustment disorder with anxiety, Eczema, Intentional dose omission, Psoriasis, Rash, Dermatitis psoriasiform, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 38 | 26557425 |
US |
2 | |
Rash, |
||||
DUPILUMAB, |
||||
| 39 | 26557439 |
US |
83 | 1 |
Rash, Product dose omission issue, Therapeutic response decreased, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 40 | 26557443 |
US |
51 | 1 |
Urticaria, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 41 | 26557481 |
CA |
41 | 2 |
Ileal stenosis, Weight decreased, Constipation, Rash, Urinary tract infection, Headache, Skin mass, Fatigue, Pain of skin, Rash erythematous, |
||||
RISANKIZUMAB-RZAA, |
||||
| 42 | 26557492 |
US |
63 | 2 |
Pain, Rash, Discomfort, Sleep disorder due to a general medical condition, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 43 | 26557493 |
US |
2 | |
Rash, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 44 | 26557541 |
US |
2 | |
Discomfort, Rash, Pruritus, Pain, Product dose omission issue, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 45 | 26557550 |
29 | ||
Arrhythmia, Sensation of foreign body, Dyspnoea, Chest discomfort, Nausea, Rash, |
||||
| 46 | 26557556 |
US |
12 | 1 |
Asthma, Rash, |
||||
DUPILUMAB, |
||||
| 47 | 26557561 |
US |
2 | |
Rash, |
||||
DUPILUMAB, |
||||
| 48 | 26557564 |
US |
2 | |
Pain, Eczema, Rash, |
||||
DUPILUMAB, |
||||
| 49 | 26557587 |
US |
16 | 2 |
Food allergy, Rash, |
||||
DUPILUMAB, |
||||
| 50 | 26557727 |
US |
2 | |
Rash, |
||||
ATOGEPANT, |
||||
| 51 | 26557753 |
US |
2 | |
Rash, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 52 | 26557807 |
EU |
47 | |
Toxic skin eruption, Pyrexia, Rash, Off label use, |
||||
RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, BISOPROLOL FUMARATE, NIFEDIPINE, AZATHIOPRINE, |
||||
| 53 | 26557921 |
CO |
64 | 1 |
Death, Perforation, Rash, |
||||
PANITUMUMAB, |
||||
| 54 | 26557970 |
US |
68 | 2 |
Rash, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 55 | 26557978 |
US |
35 | 1 |
Rash, Rash pruritic, Impaired quality of life, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, ACYCLOVIR, |
||||
| 56 | 26558032 |
US |
2 | |
Rash, |
||||
DUPILUMAB, BUPROPION, CALCIUM, LORATADINE, LORATADINE TABLET, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUTICASONE PROPIONATE, MONTELUKAST SODIUM, MONTELUKAST, NALTREXONE, SACCHAROMYCES CEREVISIAE, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, OMALIZUMAB, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 57 | 26558046 |
US |
||
Rash, Dermatitis, Pruritus, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 58 | 26558055 |
US |
2 | |
Rash, |
||||
DUPILUMAB, DESONIDE, IRON, |
||||
| 59 | 26558062 |
US |
2 | |
Anxiety, Rash, |
||||
DUPILUMAB, |
||||
| 60 | 26558143 |
US |
2 | |
Pain, Muscle rigidity, Rash, |
||||
DUPILUMAB, |
||||
| 61 | 26558180 |
|||
Rash, |
||||
BIMEKIZUMAB, |
||||
| 62 | 26558376 |
CN |
||
Leukopenia, Pancytopenia, Fatigue, Neutropenia, Decreased appetite, Thrombocytopenia, Vomiting, Nausea, Transaminases increased, Liver function test abnormal, Diarrhoea, Pneumonitis, Autoimmune thyroiditis, Rash, Procedural pain, Pneumonia, Anaemia, Wound complication, |
||||
ATEZOLIZUMAB, DURVALUMAB, ETOPOSIDE, CISPLATIN, CARBOPLATIN, |
||||
| 63 | 26558394 |
CN |
78 | 2 |
Anaphylactic shock, Eyelid oedema, Conjunctival oedema, Erythema, Pruritus, Chest discomfort, Tachypnoea, Dizziness, Blood pressure decreased, Heart rate increased, Dyspnoea, Rash, |
||||
TOBRAMYCIN, |
||||
| 64 | 26558522 |
US |
||
Rash, Product dose omission issue, Device defective, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 65 | 26558540 |
US |
43 | |
Rash, Sleep disorder, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 66 | 26558718 |
GB |
88 | 2 |
Rash, Dyspnoea, |
||||
MEMANTINE, MEMANTINE HYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, DONEPEZIL HYDROCHLORIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LACTULOSE, PRAMIPEXOLE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 67 | 26558769 |
KR |
54 | 2 |
Hyperkalaemia, Rash, Oedema peripheral, Paronychia, |
||||
| 68 | 26558811 |
US |
56 | 1 |
Headache, Dry skin, Rash, Pruritus, |
||||
TRALOKINUMAB-LDRM, |
||||
| 69 | 26558812 |
CA |
63 | 2 |
Arthralgia, Arthropathy, C-reactive protein abnormal, C-reactive protein increased, Condition aggravated, Contraindicated product administered, Disability, Drug hypersensitivity, Drug ineffective, Drug-induced liver injury, Fall, Fatigue, Femur fracture, Haematocrit decreased, Haemoglobin decreased, Impaired healing, Joint swelling, Multiple fractures, Musculoskeletal pain, Osteoporosis, Pain, Pain in extremity, Peripheral swelling, Rash, Red blood cell count decreased, Red blood cell sedimentation rate abnormal, Rheumatoid arthritis, Synovitis, |
||||
TOCILIZUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, |
||||
| 70 | 26558848 |
US |
18 | |
Eczema herpeticum, Pain of skin, Skin burning sensation, Pruritus, Eczema, Rash, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, DUPILUMAB, UPADACITINIB, |
||||
| 71 | 26558930 |
|||
Rash, Drug ineffective, |
||||
BIMEKIZUMAB, DAPAGLIFLOZIN, ADALIMUMAB, INSULIN GLARGINE, LOSARTAN POTASSIUM, LOSARTAN, IBUPROFEN, SIMVASTATIN, DULAGLUTIDE, |
||||
| 72 | 26558933 |
US |
72 | 2 |
Rash, Product quality issue, |
||||
LENALIDOMIDE, |
||||
| 73 | 26558964 |
GB |
88 | 2 |
Rash, Dyspnoea, |
||||
MEMANTINE, MEMANTINE HYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, DONEPEZIL HYDROCHLORIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, LACTULOSE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PRAMIPEXOLE, |
||||
| 74 | 26559041 |
US |
||
Rash, |
||||
VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR, |
||||
| 75 | 26559083 |
GB |
53 | 1 |
Alcohol poisoning, Accidental overdose, Abdominal discomfort, Burns second degree, Cardiac murmur, Catarrh, Cerebrovascular accident, Confusional state, Drug ineffective, Depression, Dysgeusia, Fatigue, Eczema, Frequent bowel movements, Gingival pain, Haematochezia, Hypopnoea, Inappropriate schedule of product administration, Migraine, Headache, Nightmare, Off label use, Pain, Pain in extremity, Palpitations, Parosmia, Pulmonary embolism, Pyrexia, Rash, Rectal haemorrhage, Rhinitis, Somnolence, Steroid dependence, Stress, Swollen tongue, Systemic lupus erythematosus, Tinnitus, Tubulointerstitial nephritis, Vertigo, Weight decreased, Impaired quality of life, Loss of personal independence in daily activities, Impaired work ability, Medication error, Product use in unapproved indication, Intentional product use issue, |
||||
CANDESARTAN CILEXETIL, LATANOPROST, FESOTERODINE FUMARATE, BUDESONIDE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, ROSUVASTATIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, DAPAGLIFLOZIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN, HYDROCORTISONE ACETATE, HYDROCORTISONE, VEDOLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OXYCODONE, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, WARFARIN SODIUM, WARFARIN, VEDOLIZUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FUROSEMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ADALIMUMAB, INFLIXIMAB-DYYB, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, DESOXIMETASONE, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PRAVASTATIN SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RAMIPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ESOMEPRAZOLE MAGNESIUM, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE, RIVAROXABAN, METHOTREXATE, METHOTREXATE SODIUM, TAMSULOSIN HYDROCHLORIDE, FOLIC ACID, TOFACITINIB, BISOPROLOL FUMARATE, EMPAGLIFLOZIN, LANSOPRAZOLE, NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, PREGABALIN, LATANOPROST, MINERAL OIL, NAPHAZOLINE HYDROCHLORIDE, TETRAHYDROZOLINE HYDROCHLORIDE, CAFFEINE, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, CALCIUM CARBONATE, ANTACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, DAPAGLIFLOZIN, LATANOPROST, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, ROSUVASTATIN, ROSUVASTATIN, HYDROCORTISONE ACETATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, DESOXIMETASONE, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, ADALIMUMAB, ADALIMUMAB, VEDOLIZUMAB, WARFARIN SODIUM, WARFARIN, OXYCODONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ROSUVASTATIN, |
||||
| 76 | 26559096 |
GB |
||
Death, Cytokine release syndrome, General physical health deterioration, Rash, Nausea, |
||||
TEBENTAFUSP, |
||||
| 77 | 26559169 |
US |
2 | |
Contusion, Medial tibial stress syndrome, Influenza like illness, Pyrexia, Swelling, Rash, |
||||
ZOLEDRONIC ACID, |
||||
| 78 | 26559230 |
CA |
45 | 2 |
Abdominal discomfort, Arthralgia, Autoimmune disorder, Blood cholesterol increased, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Drug ineffective, Eye injury, Folliculitis, Gait inability, Gastrointestinal disorder, Headache, Helicobacter infection, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Incorrect route of product administration, Infection, Irritable bowel syndrome, Liver disorder, Lower respiratory tract infection, Lupus vulgaris, Maternal exposure during pregnancy, Muscle injury, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Pemphigus, Peripheral swelling, Off label use, Pruritus, Rash, Rheumatic fever, Rheumatoid factor positive, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Vomiting, Wheezing, Wound, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, |
||||
| 79 | 26559232 |
US |
2 | |
Dizziness, Feeling abnormal, Pruritus, Pyrexia, Nausea, Rash, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 80 | 26559247 |
US |
54 | |
Rash, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 81 | 26559414 |
US |
64 | |
Rash, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, |
||||
| 82 | 26559430 |
EU |
63 | 2 |
Aphthous ulcer, Pneumonia, Rash, |
||||
PEMBROLIZUMAB, NEBIVOLOL HYDROCHLORIDE, CARBAMAZEPINE, |
||||
| 83 | 26559442 |
US |
78 | 1 |
Rash, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 84 | 26559487 |
US |
2 | |
Rash, |
||||
ESTRADIOL, |
||||
| 85 | 26559506 |
US |
||
Rash, Pruritus, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 86 | 26559518 |
JP |
70 | 1 |
Renal impairment, Myelosuppression, Rash, Wrong technique in product usage process, Therapy cessation, |
||||
BEMPEDOIC ACID, EZETIMIBE, ROSUVASTATIN, ROSUVASTATIN, |
||||
| 87 | 26559545 |
US |
2 | |
T-cell lymphoma, Eczema, Rash pruritic, Rash, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, CALCIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SIMVASTATIN, CETIRIZINE HYDROCHLORIDE, MINOXIDIL, |
||||
| 88 | 26559859 |
US |
1 | |
Swelling face, Rash, Feeling hot, Dizziness, Off label use, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, |
||||
| 89 | 26559870 |
US |
1 | |
Rash, |
||||
PEGVALIASE-PQPZ, |
||||
| 90 | 26559916 |
US |
58 | 2 |
Hypersensitivity, Rash, Erythema, Swelling, Skin disorder, Pruritus, |
||||
INCLISIRAN, INCLISIRAN, |
||||
| 91 | 26559994 |
US |
48 | |
Rash, Pruritus, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 92 | 26560075 |
EU |
69 | 1 |
Stoma prolapse, Rash, |
||||
PANITUMUMAB, |
||||
| 93 | 26560092 |
2 | ||
Rash, Pruritus, Dizziness, |
||||
IRON SUCROSE, IRON SUCROSE, |
||||
| 94 | 26560118 |
US |
75 | 2 |
Rash, |
||||
DUPILUMAB, |
||||
| 95 | 26560142 |
37 | 1 | |
Neuropathy peripheral, Rash, |
||||
CETUXIMAB, |
||||
| 96 | 26560162 |
US |
43 | |
Rash, |
||||
ENSARTINIB, |
||||
| 97 | 26560213 |
US |
2 | |
Rash, |
||||
DUPILUMAB, |
||||
| 98 | 26560223 |
US |
65 | 1 |
Peripheral swelling, Rash, Injection site pain, |
||||
DUPILUMAB, |
||||
| 99 | 26560252 |
US |
54 | 1 |
Rash, Pruritus, Skin burning sensation, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 100 | 26560272 |
US |
50 | 1 |
Eczema, Skin irritation, Pruritus, Rash, |
||||
DUPILUMAB, DUPILUMAB, UPADACITINIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28
